Hyperfine, Inc. (NASDAQ:HYPR) Given Consensus Rating of “Hold” by Analysts

Hyperfine, Inc. (NASDAQ:HYPR) has been given a consensus rating of “Hold” by the five ratings firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $2.0333.

A number of brokerages have issued reports on HYPR. B. Riley Financial reissued a “buy” rating and set a $1.60 price objective (down from $2.00) on shares of Hyperfine in a research report on Monday, August 10th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research report on Friday, July 17th. Finally, BTIG Research started coverage on shares of Hyperfine in a research report on Wednesday, April 29th. They issued a “buy” rating and a $2.00 target price for the company.

Hedge Funds Weigh In On Hyperfine

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in Hyperfine by 5.7% during the 3rd quarter. Vanguard Group Inc. now owns 3,511,972 shares of the company’s stock valued at $5,092,000 after acquiring an additional 190,136 shares in the last quarter. Sanctuary Advisors LLC grew its holdings in shares of Hyperfine by 130.9% during the 4th quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock worth $39,000 after acquiring an additional 22,638 shares during the period. Tortoise Investment Management LLC raised its position in shares of Hyperfine by 60.0% in the 4th quarter. Tortoise Investment Management LLC now owns 72,000 shares of the company’s stock worth $71,000 after acquiring an additional 27,000 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Hyperfine by 21.4% in the 4th quarter. Geode Capital Management LLC now owns 815,986 shares of the company’s stock worth $799,000 after acquiring an additional 143,975 shares in the last quarter. Finally, Cerity Partners LLC purchased a new position in shares of Hyperfine in the 4th quarter valued at approximately $59,000. 15.03% of the stock is owned by institutional investors.

Hyperfine Price Performance

HYPR opened at $0.90 on Tuesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 5.45 and a current ratio of 6.15. Hyperfine has a 52-week low of $0.85 and a 52-week high of $2.22. The stock has a market capitalization of $95.00 million, a PE ratio of -2.36 and a beta of 1.43. The stock’s 50 day moving average price is $1.16 and its 200-day moving average price is $1.24.

Hyperfine (NASDAQ:HYPR) last announced its earnings results on Thursday, August 6th. The company reported ($0.09) EPS for the quarter, meeting analysts’ consensus estimates of ($0.09). Hyperfine had a negative return on equity of 97.88% and a negative net margin of 210.75%.The company had revenue of $3.90 million during the quarter, compared to the consensus estimate of $4.13 million. On average, equities research analysts predict that Hyperfine will post -0.34 EPS for the current year.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.